Bruker BRKR Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Revenue by Business | |||||
| Bsi Biospin | $878.8M-3.0% | $905.7M— | —— | —— | |
| Bsi Calid | $1.21B+10.7% | $1.09B— | —— | —— | |
| Bsi Nano | $1.08B-1.3% | $1.1B— | —— | $787M+12.8% | |
| Energy And Supercon Technologies | $270.9M-4.3% | $283M+0.8% | $280.7M+18.4% | $237.1M+5.9% | |
| Revenue by Product | |||||
| Product And Service Other | $670.1M+10.4% | $607.2M+19.8% | $506.9M+59.6% | $317.6M+4,192% | |
| Product | $2.77B+0.3% | $2.76B+12.3% | $2.46B+16.5% | $2.11B+4.6% | |
| Revenue by Geography | |||||
| Asia Pacific Excluding China | $552.6M+6.6% | $518.5M+12.5% | $460.9M— | —— | |
| CN | $475.8M+1.0% | $471.2M-10.8% | $528.1M+33.2% | $396.5M+10.9% | |
| DE | $297M-4.4% | $310.7M+10.4% | $281.5M+13.8% | $247.4M-5.8% | |
| Europe Excluding Germany | $950.2M+8.8% | $873M+24.8% | $699.7M— | —— | |
| Other Country | $269.6M+5.9% | $254.5M+17.5% | $216.6M+13.8% | $190.4M+13.9% | |
| US | $891.3M-5.0% | $938.5M+20.7% | $777.7M+11.7% | $696.1M+15.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Bruker break its business down?
- Bruker (BRKR) reports revenue by business across 4 parts — Bsi Biospin, Bsi Calid, Bsi Nano and Energy And Supercon Technologies. Each is extracted from the segment footnotes and tracked over time.
- Where does Bruker's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Bruker's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
